NEO · NASDAQ
NeoGenomics (NEO) Stock Price & Fundamentals
NeoGenomics (NEO) closed at $649.58 on Oct 9, 2026, up 0.07% from the previous close of $649.14.
Share price, past year
1Y +9.27%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $649.58 |
| Sep 30, 2026 | $637.34 |
| Aug 31, 2026 | $636.84 |
| Jul 31, 2026 | $640.38 |
| Jun 30, 2026 | $616.98 |
| May 29, 2026 | $623.00 |
| Apr 30, 2026 | $599.55 |
| Mar 31, 2026 | $607.92 |
| Feb 27, 2026 | $585.92 |
| Jan 30, 2026 | $585.93 |
| Dec 31, 2025 | $617.06 |
| Nov 28, 2025 | $633.79 |
| Oct 31, 2025 | $607.51 |
Key statistics
- Market cap
- $83.09B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $766.30M
- Net income (TTM)
- −$51.88M
- Shares outstanding
- 127.9M
- Dividend yield
- —
- 52-week range
- $579.10 – $654.22
NeoGenomics's market cap is $83.09B, based on a share price of $649.58 and 127.9M shares outstanding as of Jun 30, 2026.
Financials
NeoGenomics reported revenue of $727.33M for fiscal 2025, up 10.11% from fiscal 2024.
NeoGenomics reported a net loss of $108.03M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $727.33M | +10.1% | −$108.03M | −14.9% | — | −$21.78M |
| FY2024ended Dec 31, 2024 | $660.57M | +11.7% | −$78.73M | −11.9% | — | −$34.04M |
| FY2023ended Dec 31, 2023 | $591.64M | +16.1% | −$87.97M | −14.9% | — | −$30.71M |
| FY2022ended Dec 31, 2022 | $509.73M | +5.2% | −$144.25M | −28.3% | — | −$96.88M |
| FY2021ended Dec 31, 2021 | $484.33M | +9.0% | −$8.35M | −1.7% | — | −$90.87M |
| FY2020ended Dec 31, 2020 | $444.45M | +8.7% | $4.17M | 0.9% | — | −$27.64M |
| FY2019ended Dec 31, 2019 | $408.83M | +47.7% | $8.01M | 2.0% | — | $3.34M |
| FY2018ended Dec 31, 2018 | $276.74M | +15.2% | $2.64M | 1.0% | — | $30.48M |
| FY2017ended Dec 31, 2017 | $240.25M | +3.6% | −$396.00K | −0.2% | — | $4.35M |
| FY2016ended Dec 31, 2016 | $231.81M | — | −$6.14M | −2.7% | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $201.66M | $2.24M | — |
| Q1 FY2026ended Mar 31, 2026 | $186.67M | −$17.11M | — |
| Q4 FY2025ended Dec 31, 2025 | $190.17M | −$9.88M | — |
| Q3 FY2025ended Sep 30, 2025 | $187.80M | −$27.13M | — |
| Q2 FY2025ended Jun 30, 2025 | $181.33M | −$45.09M | — |
| Q1 FY2025ended Mar 31, 2025 | $168.04M | −$25.92M | — |
| Q4 FY2024ended Dec 31, 2024 | $172.00M | −$15.32M | — |
| Q3 FY2024ended Sep 30, 2024 | $167.82M | −$17.70M | — |
Company profile
- Name
- NeoGenomics, Inc.
- Ticker
- NEO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Testing Laboratories
- Headquarters
- 9490 Neogenomics Way, Fort Myers, FL 33912
- Incorporated in
- NV
- Fiscal year ends
- December
- SEC CIK
- 0001077183
Recent SEC filings
- Oct 5, 2026
- Aug 11, 2026
- Jul 28, 2026
- Jul 28, 2026
- Jul 20, 2026
- Jun 25, 2026
- Jun 22, 2026
- Jun 17, 2026
Frequently asked questions
What is NeoGenomics's stock price?
NeoGenomics (NEO) closed at $649.58 on Oct 9, 2026, up 0.07% from the previous close of $649.14.
What is NeoGenomics's market cap?
NeoGenomics's market cap is $83.09B, based on a share price of $649.58 and 127.9M shares outstanding as of Jun 30, 2026.
How much revenue does NeoGenomics make?
NeoGenomics reported revenue of $727.33M for fiscal 2025, up 10.11% from fiscal 2024.
Does NeoGenomics pay a dividend?
NeoGenomics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from NeoGenomics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures